D. E. Shaw & Co., Inc. Legend Biotech Corp Transaction History

D. E. Shaw & Co., Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$55.06 - $69.99 $7.11 Million - $9.04 Million	-129,207 Reduced 75.95%	40,922 $2.3 Million
Q4 2023 Feb 14, 2024	SELL	$57.25 - $69.74 $916,400 - $1.12 Million	-16,007 Reduced 8.6%	170,129 $10.2 Million
Q3 2023 Nov 14, 2023	SELL	$63.16 - $76.5 $4.99 Million - $6.05 Million	-79,029 Reduced 29.8%	186,136 $12.5 Million
Q2 2023 Aug 14, 2023	BUY	$46.28 - $75.01 $6.69 Million - $10.8 Million	144,597 Added 119.93%	265,165 $18.3 Million
Q1 2023 May 15, 2023	SELL	$43.42 - $57.37 $12.3 Million - $16.2 Million	-282,429 Reduced 70.08%	120,568 $5.81 Million
Q4 2022 Feb 14, 2023	SELL	$38.8 - $55.46 $4.28 Million - $6.12 Million	-110,392 Reduced 21.5%	402,997 $20.1 Million
Q3 2022 Nov 14, 2022	BUY	$38.15 - $57.1 $14.9 Million - $22.2 Million	389,499 Added 314.39%	513,389 $20.9 Million
Q2 2022 Aug 15, 2022	SELL	$33.54 - $55.0 $8.08 Million - $13.3 Million	-241,032 Reduced 66.05%	123,890 $6.81 Million
Q1 2022 May 16, 2022	SELL	$31.02 - $48.18 $2.11 Million - $3.28 Million	-68,174 Reduced 15.74%	364,922 $13.3 Million
Q4 2021 Feb 14, 2022	BUY	$41.14 - $56.98 $4.64 Million - $6.43 Million	112,787 Added 35.21%	433,096 $20.2 Million
Q3 2021 Nov 15, 2021	BUY	$35.31 - $50.56 $4.34 Million - $6.21 Million	122,796 Added 62.17%	320,309 $16.2 Million
Q2 2021 Aug 16, 2021	BUY	$25.8 - $41.09 $5.1 Million - $8.12 Million	197,513 New	197,513 $8.11 Million

212

77.9M

412K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.73B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.